Home > Publications database > Gene context drift identifies drug targets to mitigate cancer treatment resistance. |
Journal Article | DKFZ-2025-01319 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2025
Cell Press
Cambridge, Mass.
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.ccell.2025.06.005
Abstract: Cancer treatment often fails because combinations of different therapies evoke complex resistance mechanisms that are hard to predict. We introduce REsistance through COntext DRift (RECODR): a computational pipeline that combines co-expression graph networks of single-cell RNA sequencing profiles with a graph-embedding approach to measure changes in gene co-expression context during cancer treatment. RECODR is based on the idea that gene co-expression context, rather than expression level alone, reveals important information about treatment resistance. Analysis of tumors treated in preclinical and clinical trials using RECODR unmasked resistance mechanisms -invisible to existing computational approaches- enabling the design of highly effective combination treatments for mice with choroid plexus carcinoma, and the prediction of potential new treatments for patients with medulloblastoma and triple-negative breast cancer. Thus, RECODR may unravel the complexity of cancer treatment resistance by detecting context-specific changes in gene interactions that determine the resistant phenotype.
Keyword(s): DNA repair ; cancer ; choroid plexus ; choroid plexus carcinoma ; combination therapy ; graph networks ; machine learning ; radiation ; treatment resistance ; triple-negative breast cancer
![]() |
The record appears in these collections: |